Quiet essentials · Free shipping over $75 · Shop the edit
foxo4-dri senolytic peptide human trial 2024

foxo4-dri senolytic peptide human trial 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions

SKU: 17499908454

4.0
USD25.76 USD66.76

Pay in 4 interest-free payments of $6.44 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 27 - Aug 1

Description

Molecular Characteristics Molecular Type: Synthetic tetrapeptide bioregulator Structure: Linear peptide composed of four amino acids CAS Identifier: 307297-39-8 Form: Encapsulated research compound Molecular Weight: Approximately 390.4 Da Stability: High when stored under recommended laboratory conditions Stability and Storage Guidelines Store capsules in a cool, dry environment Long-term storage recommended at 20C Protect from moisture and prolonged light exposure Avoid elevated temperatures during handling Maintain sealed container to preserve compound stability Solubility and Laboratory Compatibility Bacteriostatic water Sterile saline solutions Mild acidic laboratory buffers Selected organic analytical solvents Technical Specifications product Name Epitalon 1mg (60 Capsules) brand BioPeptides cas 307297-39-8 purity 99% (HPLC verified) unit Size 1 mg per capsule total Content 60 capsules form Encapsulated synthetic peptide synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear synthetic tetrapeptide stability High when stored appropriately Analytical Validation and Quality Assurance High-Performance Liquid Chromatography (HPLC) purity verification Mass Spectrometry molecular identity confirmation UV spectrophotometric concentration validation Batch-to-batch consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement Epitalon 1mg (60 Capsules) supplied by BioPeptides is intended strictly for laboratory research and scientific investigation

foxo4-dri senolytic peptide human trial 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions

In addition to inhibitory effects on the enzymes in TAG hydrolysis, insulin also decreases measurable rates of lipolysis (as indicated by the release of free fatty acids and glycerol from intact cells) by promoting the re-esterification of fatty acids (16)

foxo4-dri senolytic peptide human trial 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions

Injectable BPC-157 is best for systemic tissue repair , inflammation control, and vascular recovery

foxo4-dri senolytic peptide human trial 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions

While opioid receptors and their corresponding genes are involved in mechanisms related to pain and reward pathways (Le Merrer et al

foxo4-dri senolytic peptide human trial 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide Inhibitors Targeting FOXO4-p53 Interactions
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

GHK-CU

US$ 25.31

4.8 (6 reviews)

recommand products